Advertisement
Home Tags Arthritis: Misc.

Tag: Arthritis: Misc.

September 2015 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for September 2015. This roundup includes the latest...

August 2015 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for August 2015. This roundup includes the latest...
Patients with psoriasis are at higher risk of developing arrhythmia

Psoriasis Patients at Higher Risk for Arrhythmia

Findings in patients with mild, severe disease and with/without psoriatic arthritis
Oral contraceptive exposure is associated with better patient-reported outcomes in early inflammatory arthritis

Oral Contraceptive Use May Moderate Inflammatory Arthritis

OC use linked to better Rheumatoid Arthritis Impact of Disease scores over two years

July 2015 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for July 2015. This roundup includes the latest...
There is an increased risk of depression among women with psoriasis

Higher Risk for Depression With Psoriasis

Findings among women with psoriasis, psoriatic arthritis
Antibiotic use may increase the risk of juvenile idiopathic arthritis

Antibiotic Use Linked to Higher Odds of Juvenile Arthritis

Risk greatest within a year of receiving antibiotics; increases with number of courses prescribed
Many newly diagnosed psoriatic arthritis patients have an increased risk of future cardiovascular disease

Risk of CVD Up in Newly Diagnosed Psoriatic Arthritis

Ten-year cumulative incidence of CVD events higher than predicted incidence based on FRS

June 2015 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for June 2015. This roundup includes the latest...
For children with polyarticular juvenile idiopathic arthritis

TNF Inhibitors May Not Modify Polyarticular JIA Disease Process

High relapse rate particularly after discontinuation of tumor necrosis factor inhibitor before methotrexate